评估慢性肾脏疾病风险的降低:一个大规模的多国声明偏好方法。

IF 2 4区 经济学 Q2 ECONOMICS
Chris Dockins, Damien Dussaux, Charles Griffiths, Sandra Hoffmann, Nathalie Simon
{"title":"评估慢性肾脏疾病风险的降低:一个大规模的多国声明偏好方法。","authors":"Chris Dockins, Damien Dussaux, Charles Griffiths, Sandra Hoffmann, Nathalie Simon","doi":"10.1017/bca.2024.16","DOIUrl":null,"url":null,"abstract":"<p><p>Compromised kidney function is associated with an array of environmental contaminants and pathogens that may be considered for regulation. However, there are few valuation estimates for kidney effects for use in benefit-cost analyses, particularly willingness-to-pay estimates. This paper is one of several surveys valuing morbidity developed by the OECD Surveys to elicit Willingness-to-pay to Avoid Chemicals-related negative Health Effects project, which aims to improve the basis for benefit-cost analyses. We report the results of a stated preference survey valuing reduced the risk of symptomatic chronic kidney disease, filling an important gap in the valuation literature and addressing a need for applied benefits analysis of chemical regulation. The survey was administered to representative samples in each of 10 countries: Canada, Chile, China, Denmark, Germany, Italy, Norway, Türkiye, the United Kingdom, and the United States. The mean (median) WTP for an average reduction of 3.5 in 1,000 of the risk of serious kidney disease over 5 years is $2,609 ($764), corresponding to a mean (median) value per statistical case (VSC) of chronic kidney disease of $805,000 ($224,000). The mean VSC varies between $700,000 for Canada and $1,200,000 for Türkiye.</p>","PeriodicalId":45587,"journal":{"name":"Journal of Benefit-Cost Analysis","volume":"15 ","pages":"142-162"},"PeriodicalIF":2.0000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11980899/pdf/","citationCount":"0","resultStr":"{\"title\":\"Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach.\",\"authors\":\"Chris Dockins, Damien Dussaux, Charles Griffiths, Sandra Hoffmann, Nathalie Simon\",\"doi\":\"10.1017/bca.2024.16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Compromised kidney function is associated with an array of environmental contaminants and pathogens that may be considered for regulation. However, there are few valuation estimates for kidney effects for use in benefit-cost analyses, particularly willingness-to-pay estimates. This paper is one of several surveys valuing morbidity developed by the OECD Surveys to elicit Willingness-to-pay to Avoid Chemicals-related negative Health Effects project, which aims to improve the basis for benefit-cost analyses. We report the results of a stated preference survey valuing reduced the risk of symptomatic chronic kidney disease, filling an important gap in the valuation literature and addressing a need for applied benefits analysis of chemical regulation. The survey was administered to representative samples in each of 10 countries: Canada, Chile, China, Denmark, Germany, Italy, Norway, Türkiye, the United Kingdom, and the United States. The mean (median) WTP for an average reduction of 3.5 in 1,000 of the risk of serious kidney disease over 5 years is $2,609 ($764), corresponding to a mean (median) value per statistical case (VSC) of chronic kidney disease of $805,000 ($224,000). The mean VSC varies between $700,000 for Canada and $1,200,000 for Türkiye.</p>\",\"PeriodicalId\":45587,\"journal\":{\"name\":\"Journal of Benefit-Cost Analysis\",\"volume\":\"15 \",\"pages\":\"142-162\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11980899/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Benefit-Cost Analysis\",\"FirstCategoryId\":\"96\",\"ListUrlMain\":\"https://doi.org/10.1017/bca.2024.16\",\"RegionNum\":4,\"RegionCategory\":\"经济学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Benefit-Cost Analysis","FirstCategoryId":"96","ListUrlMain":"https://doi.org/10.1017/bca.2024.16","RegionNum":4,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

摘要

肾功能受损与一系列环境污染物和病原体有关,可以考虑进行调节。然而,用于效益-成本分析的肾脏效应的估值估计很少,特别是支付意愿估计。本文是经合组织为避免化学品相关的负面健康影响而开展的调查中评估发病率的几项调查之一,该调查旨在改善效益-成本分析的基础。我们报告了一项评估降低症状性慢性肾脏疾病风险的既定偏好调查的结果,填补了评估文献中的重要空白,并解决了化学调节应用效益分析的需要。这项调查是对10个国家的代表性样本进行的:加拿大、智利、中国、丹麦、德国、意大利、挪威、土耳其、英国和美国。5年内,严重肾脏疾病风险平均降低3.5 / 1000的平均(中位数)WTP为2,609美元(764美元),对应于慢性肾脏疾病的每个统计病例(VSC)的平均(中位数)价值为805,000美元(224,000美元)。加拿大的平均自愿捐助额为70万美元,加拿大为120万美元。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach.

Compromised kidney function is associated with an array of environmental contaminants and pathogens that may be considered for regulation. However, there are few valuation estimates for kidney effects for use in benefit-cost analyses, particularly willingness-to-pay estimates. This paper is one of several surveys valuing morbidity developed by the OECD Surveys to elicit Willingness-to-pay to Avoid Chemicals-related negative Health Effects project, which aims to improve the basis for benefit-cost analyses. We report the results of a stated preference survey valuing reduced the risk of symptomatic chronic kidney disease, filling an important gap in the valuation literature and addressing a need for applied benefits analysis of chemical regulation. The survey was administered to representative samples in each of 10 countries: Canada, Chile, China, Denmark, Germany, Italy, Norway, Türkiye, the United Kingdom, and the United States. The mean (median) WTP for an average reduction of 3.5 in 1,000 of the risk of serious kidney disease over 5 years is $2,609 ($764), corresponding to a mean (median) value per statistical case (VSC) of chronic kidney disease of $805,000 ($224,000). The mean VSC varies between $700,000 for Canada and $1,200,000 for Türkiye.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.30
自引率
2.90%
发文量
22
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信